A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment
Clinical trial NCT06109233 · UNKNOWN
Trial details
- NCT number
- NCT06109233
- Sponsor
- FengYan Jin
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-10
- Primary completion
- 2025-01-10
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.